Review



rabbit anti ubiquitin anti ub polyclonal  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Proteintech rabbit anti ubiquitin anti ub polyclonal
    Rabbit Anti Ubiquitin Anti Ub Polyclonal, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 770 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti ubiquitin anti ub polyclonal/product/Proteintech
    Average 96 stars, based on 770 article reviews
    rabbit anti ubiquitin anti ub polyclonal - by Bioz Stars, 2026-03
    96/100 stars

    Images



    Similar Products

    96
    Proteintech rabbit anti ubiquitin anti ub polyclonal
    Rabbit Anti Ubiquitin Anti Ub Polyclonal, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti ubiquitin anti ub polyclonal/product/Proteintech
    Average 96 stars, based on 1 article reviews
    rabbit anti ubiquitin anti ub polyclonal - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    96
    Proteintech rabbit polyclonal 173 anti ubiquitin pan ub
    Rabbit Polyclonal 173 Anti Ubiquitin Pan Ub, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal 173 anti ubiquitin pan ub/product/Proteintech
    Average 96 stars, based on 1 article reviews
    rabbit polyclonal 173 anti ubiquitin pan ub - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    96
    Proteintech rabbit polyclonal anti ub

    Rabbit Polyclonal Anti Ub, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal anti ub/product/Proteintech
    Average 96 stars, based on 1 article reviews
    rabbit polyclonal anti ub - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    96
    Proteintech anti ub rabbit polyclonal antibody

    Anti Ub Rabbit Polyclonal Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti ub rabbit polyclonal antibody/product/Proteintech
    Average 96 stars, based on 1 article reviews
    anti ub rabbit polyclonal antibody - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    96
    Proteintech rabbit polyclonal ubiquitin anti ub
    CD9 Promotes Cardiac Hypertrophy by Regulating GP130 to Activate STAT3 (A and B) Immunoprecipitation and Western blot assays used anti-CD9 and anti-GP130 antibodies to detect GP130 binding with CD9 in cardiomyocytes, with IgG as control (n = 1). (C) Cardiomyocytes transfected with Ad CD9-shRNA or Ad Scr-shRNA underwent cycloheximide treatment (CHX). GP130 protein abundance analyzed through Western blot over time (0, 0.5, 1, and 2 h), quantified below (n = 3). (D) Effects of lysosome inhibitor CQ and proteasome inhibitor MG132 on GP130 expression in cardiomyocytes transfected with Ad CD9-shRNA or Ad Scr-shRNA examined (n = 3). (E) Cardiomyocytes transfected with Ad CD9-shRNA or Ad Scr-shRNA underwent co-IP of GP130, followed by immunoblotting of precipitates for <t>ubiquitin</t> (n = 3). (F) Cardiomyocytes transfected with Ad CD9 or Ad Control co-IP’d for GP130, followed by immunoblotting of precipitates for ubiquitin (n = 3). (G and H) Western blot assays performed on cardiomyocytes with CD9 knockdown or overexpression under Ang II stimulation, assessing CD9, GP130, p-STAT3, and STAT3 expression. GAPDH was loading control, with quantification below (n = 3). (I) Western blot nuclear plasma separation analysis of p-STAT3 nuclear translocation in cardiomyocytes transfected with Ad CD9-shRNA or Ad Scr-shRNA with or without Ang II stimulation (n = 3). (J) Representative immunofluorescence image showed p-STAT3 nuclear translocation in cardiomyocytes transfected with Ad CD9-shRNA or Ad Scr-shRNA with Ang II stimulation. Scale bar: 50 μm. (K and L) C57 mice injected with AAV CD9-shRNA or AAV CD9 two weeks pre-TAC surgery, sacrificed 4 weeks post-surgery. Western blot assays on cardiac tissues assessed CD9, GP130, p-STAT3, and STAT3 expression. GAPDH was the loading control, with quantification in the right panel (n = 3). ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
    Rabbit Polyclonal Ubiquitin Anti Ub, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal ubiquitin anti ub/product/Proteintech
    Average 96 stars, based on 1 article reviews
    rabbit polyclonal ubiquitin anti ub - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    98
    Cell Signaling Technology Inc rabbit polyclonal antibody against ub
    CD9 Promotes Cardiac Hypertrophy by Regulating GP130 to Activate STAT3 (A and B) Immunoprecipitation and Western blot assays used anti-CD9 and anti-GP130 antibodies to detect GP130 binding with CD9 in cardiomyocytes, with IgG as control (n = 1). (C) Cardiomyocytes transfected with Ad CD9-shRNA or Ad Scr-shRNA underwent cycloheximide treatment (CHX). GP130 protein abundance analyzed through Western blot over time (0, 0.5, 1, and 2 h), quantified below (n = 3). (D) Effects of lysosome inhibitor CQ and proteasome inhibitor MG132 on GP130 expression in cardiomyocytes transfected with Ad CD9-shRNA or Ad Scr-shRNA examined (n = 3). (E) Cardiomyocytes transfected with Ad CD9-shRNA or Ad Scr-shRNA underwent co-IP of GP130, followed by immunoblotting of precipitates for <t>ubiquitin</t> (n = 3). (F) Cardiomyocytes transfected with Ad CD9 or Ad Control co-IP’d for GP130, followed by immunoblotting of precipitates for ubiquitin (n = 3). (G and H) Western blot assays performed on cardiomyocytes with CD9 knockdown or overexpression under Ang II stimulation, assessing CD9, GP130, p-STAT3, and STAT3 expression. GAPDH was loading control, with quantification below (n = 3). (I) Western blot nuclear plasma separation analysis of p-STAT3 nuclear translocation in cardiomyocytes transfected with Ad CD9-shRNA or Ad Scr-shRNA with or without Ang II stimulation (n = 3). (J) Representative immunofluorescence image showed p-STAT3 nuclear translocation in cardiomyocytes transfected with Ad CD9-shRNA or Ad Scr-shRNA with Ang II stimulation. Scale bar: 50 μm. (K and L) C57 mice injected with AAV CD9-shRNA or AAV CD9 two weeks pre-TAC surgery, sacrificed 4 weeks post-surgery. Western blot assays on cardiac tissues assessed CD9, GP130, p-STAT3, and STAT3 expression. GAPDH was the loading control, with quantification in the right panel (n = 3). ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
    Rabbit Polyclonal Antibody Against Ub, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal antibody against ub/product/Cell Signaling Technology Inc
    Average 98 stars, based on 1 article reviews
    rabbit polyclonal antibody against ub - by Bioz Stars, 2026-03
    98/100 stars
      Buy from Supplier

    90
    Cell Signaling Technology Inc rabbit anti-ubiquitin (ub) polyclonal antibody (pab)
    CD9 Promotes Cardiac Hypertrophy by Regulating GP130 to Activate STAT3 (A and B) Immunoprecipitation and Western blot assays used anti-CD9 and anti-GP130 antibodies to detect GP130 binding with CD9 in cardiomyocytes, with IgG as control (n = 1). (C) Cardiomyocytes transfected with Ad CD9-shRNA or Ad Scr-shRNA underwent cycloheximide treatment (CHX). GP130 protein abundance analyzed through Western blot over time (0, 0.5, 1, and 2 h), quantified below (n = 3). (D) Effects of lysosome inhibitor CQ and proteasome inhibitor MG132 on GP130 expression in cardiomyocytes transfected with Ad CD9-shRNA or Ad Scr-shRNA examined (n = 3). (E) Cardiomyocytes transfected with Ad CD9-shRNA or Ad Scr-shRNA underwent co-IP of GP130, followed by immunoblotting of precipitates for <t>ubiquitin</t> (n = 3). (F) Cardiomyocytes transfected with Ad CD9 or Ad Control co-IP’d for GP130, followed by immunoblotting of precipitates for ubiquitin (n = 3). (G and H) Western blot assays performed on cardiomyocytes with CD9 knockdown or overexpression under Ang II stimulation, assessing CD9, GP130, p-STAT3, and STAT3 expression. GAPDH was loading control, with quantification below (n = 3). (I) Western blot nuclear plasma separation analysis of p-STAT3 nuclear translocation in cardiomyocytes transfected with Ad CD9-shRNA or Ad Scr-shRNA with or without Ang II stimulation (n = 3). (J) Representative immunofluorescence image showed p-STAT3 nuclear translocation in cardiomyocytes transfected with Ad CD9-shRNA or Ad Scr-shRNA with Ang II stimulation. Scale bar: 50 μm. (K and L) C57 mice injected with AAV CD9-shRNA or AAV CD9 two weeks pre-TAC surgery, sacrificed 4 weeks post-surgery. Western blot assays on cardiac tissues assessed CD9, GP130, p-STAT3, and STAT3 expression. GAPDH was the loading control, with quantification in the right panel (n = 3). ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
    Rabbit Anti Ubiquitin (Ub) Polyclonal Antibody (Pab), supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti-ubiquitin (ub) polyclonal antibody (pab)/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    rabbit anti-ubiquitin (ub) polyclonal antibody (pab) - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology bax, ubiquitin (ub) (rabbit anti-rats bax and ub polyclonal antibody)
    CD9 Promotes Cardiac Hypertrophy by Regulating GP130 to Activate STAT3 (A and B) Immunoprecipitation and Western blot assays used anti-CD9 and anti-GP130 antibodies to detect GP130 binding with CD9 in cardiomyocytes, with IgG as control (n = 1). (C) Cardiomyocytes transfected with Ad CD9-shRNA or Ad Scr-shRNA underwent cycloheximide treatment (CHX). GP130 protein abundance analyzed through Western blot over time (0, 0.5, 1, and 2 h), quantified below (n = 3). (D) Effects of lysosome inhibitor CQ and proteasome inhibitor MG132 on GP130 expression in cardiomyocytes transfected with Ad CD9-shRNA or Ad Scr-shRNA examined (n = 3). (E) Cardiomyocytes transfected with Ad CD9-shRNA or Ad Scr-shRNA underwent co-IP of GP130, followed by immunoblotting of precipitates for <t>ubiquitin</t> (n = 3). (F) Cardiomyocytes transfected with Ad CD9 or Ad Control co-IP’d for GP130, followed by immunoblotting of precipitates for ubiquitin (n = 3). (G and H) Western blot assays performed on cardiomyocytes with CD9 knockdown or overexpression under Ang II stimulation, assessing CD9, GP130, p-STAT3, and STAT3 expression. GAPDH was loading control, with quantification below (n = 3). (I) Western blot nuclear plasma separation analysis of p-STAT3 nuclear translocation in cardiomyocytes transfected with Ad CD9-shRNA or Ad Scr-shRNA with or without Ang II stimulation (n = 3). (J) Representative immunofluorescence image showed p-STAT3 nuclear translocation in cardiomyocytes transfected with Ad CD9-shRNA or Ad Scr-shRNA with Ang II stimulation. Scale bar: 50 μm. (K and L) C57 mice injected with AAV CD9-shRNA or AAV CD9 two weeks pre-TAC surgery, sacrificed 4 weeks post-surgery. Western blot assays on cardiac tissues assessed CD9, GP130, p-STAT3, and STAT3 expression. GAPDH was the loading control, with quantification in the right panel (n = 3). ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
    Bax, Ubiquitin (Ub) (Rabbit Anti Rats Bax And Ub Polyclonal Antibody), supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bax, ubiquitin (ub) (rabbit anti-rats bax and ub polyclonal antibody)/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    bax, ubiquitin (ub) (rabbit anti-rats bax and ub polyclonal antibody) - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Agilent technologies anti-ubiquitin antibody polyclonal rabbit anti-ub
    CD9 Promotes Cardiac Hypertrophy by Regulating GP130 to Activate STAT3 (A and B) Immunoprecipitation and Western blot assays used anti-CD9 and anti-GP130 antibodies to detect GP130 binding with CD9 in cardiomyocytes, with IgG as control (n = 1). (C) Cardiomyocytes transfected with Ad CD9-shRNA or Ad Scr-shRNA underwent cycloheximide treatment (CHX). GP130 protein abundance analyzed through Western blot over time (0, 0.5, 1, and 2 h), quantified below (n = 3). (D) Effects of lysosome inhibitor CQ and proteasome inhibitor MG132 on GP130 expression in cardiomyocytes transfected with Ad CD9-shRNA or Ad Scr-shRNA examined (n = 3). (E) Cardiomyocytes transfected with Ad CD9-shRNA or Ad Scr-shRNA underwent co-IP of GP130, followed by immunoblotting of precipitates for <t>ubiquitin</t> (n = 3). (F) Cardiomyocytes transfected with Ad CD9 or Ad Control co-IP’d for GP130, followed by immunoblotting of precipitates for ubiquitin (n = 3). (G and H) Western blot assays performed on cardiomyocytes with CD9 knockdown or overexpression under Ang II stimulation, assessing CD9, GP130, p-STAT3, and STAT3 expression. GAPDH was loading control, with quantification below (n = 3). (I) Western blot nuclear plasma separation analysis of p-STAT3 nuclear translocation in cardiomyocytes transfected with Ad CD9-shRNA or Ad Scr-shRNA with or without Ang II stimulation (n = 3). (J) Representative immunofluorescence image showed p-STAT3 nuclear translocation in cardiomyocytes transfected with Ad CD9-shRNA or Ad Scr-shRNA with Ang II stimulation. Scale bar: 50 μm. (K and L) C57 mice injected with AAV CD9-shRNA or AAV CD9 two weeks pre-TAC surgery, sacrificed 4 weeks post-surgery. Western blot assays on cardiac tissues assessed CD9, GP130, p-STAT3, and STAT3 expression. GAPDH was the loading control, with quantification in the right panel (n = 3). ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
    Anti Ubiquitin Antibody Polyclonal Rabbit Anti Ub, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-ubiquitin antibody polyclonal rabbit anti-ub/product/Agilent technologies
    Average 90 stars, based on 1 article reviews
    anti-ubiquitin antibody polyclonal rabbit anti-ub - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Agilent technologies rabbit anti-ubiquitin (ub) polyclonal igg
    CD9 Promotes Cardiac Hypertrophy by Regulating GP130 to Activate STAT3 (A and B) Immunoprecipitation and Western blot assays used anti-CD9 and anti-GP130 antibodies to detect GP130 binding with CD9 in cardiomyocytes, with IgG as control (n = 1). (C) Cardiomyocytes transfected with Ad CD9-shRNA or Ad Scr-shRNA underwent cycloheximide treatment (CHX). GP130 protein abundance analyzed through Western blot over time (0, 0.5, 1, and 2 h), quantified below (n = 3). (D) Effects of lysosome inhibitor CQ and proteasome inhibitor MG132 on GP130 expression in cardiomyocytes transfected with Ad CD9-shRNA or Ad Scr-shRNA examined (n = 3). (E) Cardiomyocytes transfected with Ad CD9-shRNA or Ad Scr-shRNA underwent co-IP of GP130, followed by immunoblotting of precipitates for <t>ubiquitin</t> (n = 3). (F) Cardiomyocytes transfected with Ad CD9 or Ad Control co-IP’d for GP130, followed by immunoblotting of precipitates for ubiquitin (n = 3). (G and H) Western blot assays performed on cardiomyocytes with CD9 knockdown or overexpression under Ang II stimulation, assessing CD9, GP130, p-STAT3, and STAT3 expression. GAPDH was loading control, with quantification below (n = 3). (I) Western blot nuclear plasma separation analysis of p-STAT3 nuclear translocation in cardiomyocytes transfected with Ad CD9-shRNA or Ad Scr-shRNA with or without Ang II stimulation (n = 3). (J) Representative immunofluorescence image showed p-STAT3 nuclear translocation in cardiomyocytes transfected with Ad CD9-shRNA or Ad Scr-shRNA with Ang II stimulation. Scale bar: 50 μm. (K and L) C57 mice injected with AAV CD9-shRNA or AAV CD9 two weeks pre-TAC surgery, sacrificed 4 weeks post-surgery. Western blot assays on cardiac tissues assessed CD9, GP130, p-STAT3, and STAT3 expression. GAPDH was the loading control, with quantification in the right panel (n = 3). ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
    Rabbit Anti Ubiquitin (Ub) Polyclonal Igg, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti-ubiquitin (ub) polyclonal igg/product/Agilent technologies
    Average 90 stars, based on 1 article reviews
    rabbit anti-ubiquitin (ub) polyclonal igg - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    Image Search Results


    Journal: iScience

    Article Title: Designer polyQ fusion proteins sequester USP7/HDM2 for modulating P53 functionality

    doi: 10.1016/j.isci.2025.112025

    Figure Lengend Snippet:

    Article Snippet: Rabbit polyclonal anti-Ub , Proteintech , Cat# 10201-2-AP; RRID: AB_671515.

    Techniques: Virus, Recombinant, Protease Inhibitor, Reverse Transcription, SYBR Green Assay, Sequencing, Software

    CD9 Promotes Cardiac Hypertrophy by Regulating GP130 to Activate STAT3 (A and B) Immunoprecipitation and Western blot assays used anti-CD9 and anti-GP130 antibodies to detect GP130 binding with CD9 in cardiomyocytes, with IgG as control (n = 1). (C) Cardiomyocytes transfected with Ad CD9-shRNA or Ad Scr-shRNA underwent cycloheximide treatment (CHX). GP130 protein abundance analyzed through Western blot over time (0, 0.5, 1, and 2 h), quantified below (n = 3). (D) Effects of lysosome inhibitor CQ and proteasome inhibitor MG132 on GP130 expression in cardiomyocytes transfected with Ad CD9-shRNA or Ad Scr-shRNA examined (n = 3). (E) Cardiomyocytes transfected with Ad CD9-shRNA or Ad Scr-shRNA underwent co-IP of GP130, followed by immunoblotting of precipitates for ubiquitin (n = 3). (F) Cardiomyocytes transfected with Ad CD9 or Ad Control co-IP’d for GP130, followed by immunoblotting of precipitates for ubiquitin (n = 3). (G and H) Western blot assays performed on cardiomyocytes with CD9 knockdown or overexpression under Ang II stimulation, assessing CD9, GP130, p-STAT3, and STAT3 expression. GAPDH was loading control, with quantification below (n = 3). (I) Western blot nuclear plasma separation analysis of p-STAT3 nuclear translocation in cardiomyocytes transfected with Ad CD9-shRNA or Ad Scr-shRNA with or without Ang II stimulation (n = 3). (J) Representative immunofluorescence image showed p-STAT3 nuclear translocation in cardiomyocytes transfected with Ad CD9-shRNA or Ad Scr-shRNA with Ang II stimulation. Scale bar: 50 μm. (K and L) C57 mice injected with AAV CD9-shRNA or AAV CD9 two weeks pre-TAC surgery, sacrificed 4 weeks post-surgery. Western blot assays on cardiac tissues assessed CD9, GP130, p-STAT3, and STAT3 expression. GAPDH was the loading control, with quantification in the right panel (n = 3). ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.

    Journal: iScience

    Article Title: CD9 exacerbates pathological cardiac hypertrophy through regulating GP130/STAT3 signaling pathway

    doi: 10.1016/j.isci.2023.108070

    Figure Lengend Snippet: CD9 Promotes Cardiac Hypertrophy by Regulating GP130 to Activate STAT3 (A and B) Immunoprecipitation and Western blot assays used anti-CD9 and anti-GP130 antibodies to detect GP130 binding with CD9 in cardiomyocytes, with IgG as control (n = 1). (C) Cardiomyocytes transfected with Ad CD9-shRNA or Ad Scr-shRNA underwent cycloheximide treatment (CHX). GP130 protein abundance analyzed through Western blot over time (0, 0.5, 1, and 2 h), quantified below (n = 3). (D) Effects of lysosome inhibitor CQ and proteasome inhibitor MG132 on GP130 expression in cardiomyocytes transfected with Ad CD9-shRNA or Ad Scr-shRNA examined (n = 3). (E) Cardiomyocytes transfected with Ad CD9-shRNA or Ad Scr-shRNA underwent co-IP of GP130, followed by immunoblotting of precipitates for ubiquitin (n = 3). (F) Cardiomyocytes transfected with Ad CD9 or Ad Control co-IP’d for GP130, followed by immunoblotting of precipitates for ubiquitin (n = 3). (G and H) Western blot assays performed on cardiomyocytes with CD9 knockdown or overexpression under Ang II stimulation, assessing CD9, GP130, p-STAT3, and STAT3 expression. GAPDH was loading control, with quantification below (n = 3). (I) Western blot nuclear plasma separation analysis of p-STAT3 nuclear translocation in cardiomyocytes transfected with Ad CD9-shRNA or Ad Scr-shRNA with or without Ang II stimulation (n = 3). (J) Representative immunofluorescence image showed p-STAT3 nuclear translocation in cardiomyocytes transfected with Ad CD9-shRNA or Ad Scr-shRNA with Ang II stimulation. Scale bar: 50 μm. (K and L) C57 mice injected with AAV CD9-shRNA or AAV CD9 two weeks pre-TAC surgery, sacrificed 4 weeks post-surgery. Western blot assays on cardiac tissues assessed CD9, GP130, p-STAT3, and STAT3 expression. GAPDH was the loading control, with quantification in the right panel (n = 3). ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.

    Article Snippet: Rabbit polyclonal ubiquitin anti-ub , Proteintech , Cat# 10201-2-AP; RRID: AB_671515.

    Techniques: Immunoprecipitation, Western Blot, Binding Assay, Control, Transfection, shRNA, Quantitative Proteomics, Expressing, Co-Immunoprecipitation Assay, Ubiquitin Proteomics, Knockdown, Over Expression, Clinical Proteomics, Translocation Assay, Immunofluorescence, Injection

    Journal: iScience

    Article Title: CD9 exacerbates pathological cardiac hypertrophy through regulating GP130/STAT3 signaling pathway

    doi: 10.1016/j.isci.2023.108070

    Figure Lengend Snippet:

    Article Snippet: Rabbit polyclonal ubiquitin anti-ub , Proteintech , Cat# 10201-2-AP; RRID: AB_671515.

    Techniques: Ubiquitin Proteomics, Virus, Recombinant, shRNA, Software, Staining